(Q40976360)

25 September 2017

1 reference

title

Oral tolerance in myasthenia gravis (English)

1 reference

25 September 2017

0 references

Drachman DB

1

1 reference

25 September 2017

Okumura S

series ordinal

2

1 reference

25 September 2017

Adams RN

series ordinal

3

1 reference

25 September 2017

McIntosh KR

series ordinal

4

1 reference

25 September 2017

language of work or name

English

0 references

publication date

1 February 1996

1 reference

Annals of the New York Academy of Sciences

25 September 2017

published in

1 reference

25 September 2017

volume

778

1 reference

25 September 2017

page(s)

258-272

1 reference

The course of myasthenia gravis and therapies affecting outcome

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1996.TB21134.X

The natural course of myasthenia gravis and effect of therapeutic measures

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1996.TB21134.X

Neuromuscular Junction in Myasthenia Gravis: Decreased Acetylcholine Receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1996.TB21134.X

Cloning and sequence analysis of calf cDNA and human genomic DNA encoding alpha-subunit precursor of muscle acetylcholine receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1996.TB21134.X

The Cholinergic Receptor Protein in Its Membrane Environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1996.TB21134.X

Cloning and expression in Escherichia coli of a synthetic gene encoding the extracellular domain of the human muscle acetylcholine receptor alpha-subunit

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1996.TB21134.X

Expression of functional acetylcholine receptor from cloned cDNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1996.TB21134.X

Autoimmune Response to Acetylcholine Receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1996.TB21134.X

Antibodies to acetylcholine receptors in rabbits: immunochemical and electrophysiological studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1996.TB21134.X

Strategies for treatment of myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1996.TB21134.X

Remission of myasthenia gravis following plasma-exchange

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1996.TB21134.X

Myasthenic immunoglobulin accelerates acetylcholine receptor degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1996.TB21134.X

The membrane attack complex of complement at the endplate in myasthenia gravis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1996.TB21134.X

Long-term corticosteroid treatment of myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1996.TB21134.X

Suppression of experimental autoimmune encephalomyelitis by the oral administration of myelin basic protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1996.TB21134.X

Suppression of experimental autoimmune uveitis in rats by the oral administration of the uveitopathogenic S-antigen fragment or a cross-reactive homologous peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1996.TB21134.X

Suppression of type II collagen-induced arthritis by intragastric administration of soluble type II collagen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1996.TB21134.X

Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1996.TB21134.X

Double-Blind Pilot Trial of Oral Tolerization with Myelin Antigens in Multiple Sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1996.TB21134.X

Experimental autoimmune myasthenia: A model of myasthenia gravis in rats and guinea pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1996.TB21134.X

Induction of anergy or active suppression following oral tolerance is determined by antigen dosage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1996.TB21134.X

The regulation of immune responses to dietary protein antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1996.TB21134.X

Acetylcholine receptor channel imaged in the open state

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1996.TB21134.X

10.1111/J.1749-6632.1996.TB21134.X

21 January 2018

Identifiers

DOI

1 reference

25 September 2017

1 reference